Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Cancer Genomics Proteomics ; 18(1): 29-42, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33419894

RESUMO

BACKGROUND: Opisthorchis viverrini (Ov) infection-induced cholangiocarcinoma (CCA) is a major public health problem in northeastern Thailand. Praziquantel was shown to prevent CCA development in an Ov-infected hamster model; however, the molecular mechanism remains unknown. MATERIALS AND METHODS: In this study, we used a hamster model with Ov and N-nitrosodimethylamine-induced CCA to study the mechanisms of praziquantel action. The liver tissues from the hamsters with and without praziquantel treatment were analyzed using 1H nuclear magnetic resonance spectroscopy. RESULTS: A total of 14 metabolites were found to be significantly different between the two groups. Furthermore, the combination of acetate, inosine and sarcosine was shown to exert an anti-inflammatory effect through interleukin-6 inhibition in a macrophage cell line, suggesting a mechanism by which praziquantel may prevent inflammation caused by Ov, cholangiocyte transformation and further CCA develpoment. CONCLUSION: These findings might avail the development of a preventive strategy for CCA in high-risk populations.


Assuntos
Anti-Helmínticos/uso terapêutico , Colangiocarcinoma/complicações , Colangiocarcinoma/tratamento farmacológico , Opisthorchis/efeitos dos fármacos , Praziquantel/uso terapêutico , Animais , Anti-Helmínticos/farmacologia , Colangiocarcinoma/patologia , Cricetinae , Modelos Animais de Doenças , Humanos , Praziquantel/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA